| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.27 | 0.09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.073 | 0.09 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.22 | 0.09 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |